Clinical Outcome of Enoxaparin Therapy Among Patients Treated During the Early Stage of the COVID-19 Pandemic
Infection with severe acute respiratory syndrome coronavirus (SARS-CoV-2) is often associated with coagulation abnormalities, including increased D-dimer and fibrinogen levels, which increase the risk of thrombotic events [1-3].
Authors
- Cristina de Ancos Aracil (ORCID: https://orcid.org/0000-0002-3832-8170)
Institutions
- Hospital Universitario de Fuenlabrada (ES)
Publication Details
- Journal
- Biomedical Journal of Scientific & Technical Research
- Published
- 2024-10-15
- DOI
- https://doi.org/10.26717/bjstr.2024.59.009245
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00